Bheemanagouda Patil

Waikato Hospital, Hamilton, New Zealand

JOURNAL REVIEWED: Ophthalmic Research

Latest Contribution

Mast cells in Graves’ ophthalmopathy

1 August 2016 | | Ophthalmology | Graves’ ophthalmopathy, Histamine, Histamine receptor type-1, Loratadine, Mast cell, NF-κB controlled cytokine, NF-κB inhibitor, Orbital fibroblast

Graves’ ophthalmopathy (GO) is a potentially sight-threatening ocular disease, occurring in patients with hyperthyroidism due to Graves’ disease. Also known as thyroid-associated ophthalmopathy, GO is characterised by orbital infiltration by immune cells including macrophages, T cells and plasma cells, which...

Who will benefit from cataract surgery?

1 June 2016 | | Cataract and Refractive | cataract, evidence, indication, visual acuity

The need for cataract surgery is expected to rise dramatically in the future due to the increasing proportion of elderly citizens and increasing demands for optimum visual function. The aim of this study was to provide an evidence-based recommendation for...

Health-related quality of life after cataract surgery

1 June 2016 | | Cataract and Refractive | cataract, cataract surgery, quality of life, quality-adjusted life years

This prospective study evaluates the impact of cataract surgery on subjects’ health-related quality of life (HRQoL) measured with a 15-dimension generic instrument, the 15D. The HRQoL of cataract subjects was compared with that of an age- and gender-standardised sample of...